Product Information
ACARBOSE 25 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1760 per EA under NDC 62135045390. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Feb 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Chartwell RX LLCNDC
62135045390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACARBOSEApproval Type
Generic (ANDA)
FDA Application
ANDA202271FDA Approved
2/7/2012
TE Code
AB
On Market Since
4/16/2021
Pharmacological Classes
Price Statistics
The NADAC for ACARBOSE 25 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1760 per EA |
|---|---|
| All-time high | $0.2117 (Jul 12, 2023) |
| All-time low | $0.1199 (Nov 20, 2024) |
| 52-week high | $0.1760 |
| 52-week low | $0.1409 |
| Median price | $0.1547 |
| Average price | $0.1568 |
| Largest weekly change | +29.8% (Jun 21, 2023) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACARBOSE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACARBOSE 25 MG TABLET, manufactured by Chartwell RX LLC, is $0.1760 per EA (NDC 62135045390), effective Aug 19, 2026.
How has the price of ACARBOSE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACARBOSE 25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ACARBOSE 25 MG TABLET?
Since May 10, 2023, the NADAC for ACARBOSE 25 MG TABLET has ranged from a low of $0.1199 (Nov 20, 2024) to a high of $0.2117 (Jul 12, 2023), with a median of $0.1547 per EA.
Are there cheaper alternatives to ACARBOSE 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACARBOSE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ACARBOSE 25 MG TABLET?
ACARBOSE 25 MG TABLET (NDC 62135045390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.